GLIMITERIS TRIO 0.2:Uses, Side Effects, Dosage and Call to action....

GLIMITERIS TRIO 0.2

Voglibose 0.2 mg, Glimepiride 3 mg & Metformin Hydrochloride 500 mg

GLIMITERIS TRIO 0.2 is a combination medication used for managing type 2 diabetes mellitus. This unique formulation combines Voglibose 0.2 mg, Glimepiride 3 mg, and Metformin Hydrochloride 500 mg, each contributing to controlling blood sugar levels in different ways. By targeting multiple pathways of glucose regulation, this combination helps achieve better glycemic control and reduces the risk of diabetes-related complications.

Key Ingredients and Their Functions
Voglibose 0.2 mg
Voglibose is an alpha-glucosidase inhibitor that slows down the absorption of carbohydrates from the intestines. This helps in reducing postprandial (after-meal) blood glucose spikes, an important aspect of managing diabetes.

Glimepiride 3 mg
Glimepiride is a sulfonylurea that stimulates the release of insulin from the pancreatic beta cells. It enhances the body's response to insulin, helping to lower blood glucose levels.

Metformin Hydrochloride 500 mg
Metformin is a biguanide that reduces hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization. It is considered the first-line medication for type 2 diabetes management.

How GLIMITERIS TRIO 0.2 Works
The combination of these three drugs provides a comprehensive approach to managing type 2 diabetes:

Voglibose: By inhibiting enzymes that convert complex carbohydrates into simple sugars, Voglibose slows the entry of glucose into the bloodstream, preventing sudden spikes in blood sugar levels after meals.

Glimepiride: This medication increases the secretion of insulin, helping the body utilize glucose more effectively. By stimulating insulin release, it helps lower blood glucose levels.

Metformin Hydrochloride: Metformin works by reducing the amount of glucose produced by the liver and increasing the sensitivity of muscle cells to insulin. This dual action helps in lowering both fasting and postprandial blood glucose levels.

Uses of GLIMITERIS TRIO 0.2
GLIMITERIS TRIO 0.2 is primarily prescribed for:

Type 2 Diabetes Mellitus: It is used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.
Prevention of Diabetes Complications: By maintaining blood glucose levels within the target range, this medication helps in reducing the risk of diabetes-related complications such as neuropathy, retinopathy, and cardiovascular diseases.
Dosage and Administration
The dosage of GLIMITERIS TRIO 0.2 should be individualized based on the patient's current glycemic control, medical history, and response to therapy. It is typically taken orally once or twice daily with meals to reduce gastrointestinal side effects associated with metformin.

Recommended Dosage
Adults: One tablet taken once or twice daily with meals. The dosage may be adjusted based on the patient's response and tolerability.
Special Populations
Elderly Patients: Dose adjustments may be necessary due to the increased risk of adverse effects.
Side Effects
Like all medications, GLIMITERIS TRIO 0.2 may cause side effects. Not all patients will experience these, but it is important to be aware of potential reactions.

Common Side Effects
Hypoglycemia: Low blood sugar levels, particularly when taken with other antidiabetic medications or insulin.
Gastrointestinal Issues: Nausea, vomiting, diarrhea, and abdominal pain, mostly associated with metformin.
Weight Gain: Possible weight gain, commonly linked to glimepiride.
Dizziness: Some patients may experience dizziness or lightheadedness.
Serious Side Effects
Lactic Acidosis: A rare but serious side effect of metformin, characterized by muscle pain, difficulty breathing, stomach pain, and fatigue. Immediate medical attention is required.
Allergic Reactions: Rash, itching, swelling, or difficulty breathing may indicate an allergic reaction and require prompt medical attention.
Liver Dysfunction: Signs of liver dysfunction, such as jaundice, dark urine, or persistent nausea/vomiting, should be reported to a healthcare provider immediately.
Precautions and Warnings
Kidney Function: Regular monitoring of kidney function is essential, as metformin can accumulate in patients with renal impairment, increasing the risk of lactic acidosis.
Liver Function: Liver function tests should be conducted periodically to monitor for potential hepatic side effects.
Hypoglycemia Risk: Patients should be educated on recognizing and managing symptoms of hypoglycemia, especially when combining this medication with other glucose-lowering agents.
Pregnancy and Breastfeeding: The safety of GLIMITERIS TRIO 0.2 during pregnancy and breastfeeding has not been established. 
Drug Interactions
GLIMITERIS TRIO 0.2 may interact with other medications, potentially altering their effects. Some notable interactions include:

Beta-blockers: These may mask the symptoms of hypoglycemia.
Diuretics: May increase the risk of lactic acidosis when used with metformin.
Corticosteroids: Can increase blood glucose levels, reducing the efficacy of GLIMITERIS TRIO 0.2.
ACE Inhibitors: May enhance the hypoglycemic effect.
Conclusion
GLIMITERIS TRIO 0.2, with its combination of Voglibose, Glimepiride, and Metformin Hydrochloride, offers a comprehensive approach to managing type 2 diabetes mellitus. By addressing multiple pathways of glucose regulation, this medication helps achieve better glycemic control, reduces postprandial spikes, and enhances insulin sensitivity. Patients should follow their healthcare provider's instructions regarding dosage and administration, and be aware of potential side effects and interactions. Regular monitoring and adherence to prescribed lifestyle changes are crucial for optimizing the benefits of GLIMITERIS TRIO 0.2.Steris Healthcare Pvt Ltd, operating as Sterispharma since its founding by expert professionals in the pharmaceutical industry in February 2018, is based in Navi Mumbai. The company is certified by WHO, GMP, and ISO, emphasizing its commitment to quality and safety. Sterispharma focuses on providing high-quality drugs at affordable prices throughout India, adhering strictly to WHO guidelines. Offering the convenience of an online pharmacy, customers can easily purchase medicines with home delivery options available. Sterispharma's mission is to supply a broad range of healthcare products to meet the diverse needs of the medical community. From advanced treatments and medications for rare conditions to essential health necessities, Sterispharma aims to serve the extensive demands of the healthcare industry. You can order medicines from Sterispharma through their websites, sterisonline and sterispharma. Their extensive product lineup includes treatments for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology. 

For further information 

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp:  7877551268, 7849827488  

BUY NOW